Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024InvestorPlace • 04/11/24
CRISPR Therapeutics AG (CRSP) Annual Needham Virtual Healthcare Conference - (Transcript)Seeking Alpha • 04/10/24
CRISPR Therapeutics AG (CRSP) Exceeds Market Returns: Some Facts to ConsiderZacks Investment Research • 04/09/24
CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/03/24
CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual MeetingGlobeNewsWire • 04/01/24
Crispr Therapeutics: Upcoming Catalysts May Validate The Bull Thesis And Force A Change In PlansSeeking Alpha • 03/30/24
Crispr Stock, A Cathie Wood Holding, Dives For The Fifth Straight Week — Here's WhyInvestors Business Daily • 03/28/24
CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to KnowZacks Investment Research • 03/25/24
ChatGPT Stock Predictions: 3 Biotech Companies the AI Bot Thinks Have 10X PotentialInvestorPlace • 03/04/24
CRISPR Therapeutics Stock Has 32% Upside, According to 1 Wall Street AnalystThe Motley Fool • 02/29/24